These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Observations on the histopathologic diagnosis of microinvasive carcinoma of the breast. Prasad ML, Osborne MP, Hoda SA. Anat Pathol; 1998; 3():209-32. PubMed ID: 10389587 [Abstract] [Full Text] [Related]
8. Assessment of invasion in breast lesions using antibodies to basement membrane components and myoepithelial cells. Raymond WA, Leong AS. Pathology; 1991 Oct; 23(4):291-7. PubMed ID: 1664512 [Abstract] [Full Text] [Related]
10. Expression of c-kit in common benign and malignant breast lesions. Kondi-Pafiti A, Arkadopoulos N, Gennatas C, Michalaki V, Frangou-Plegmenou M, Chatzipantelis P. Tumori; 2010 Oct; 96(6):978-84. PubMed ID: 21388062 [Abstract] [Full Text] [Related]
14. Are epithelial cells in fat or connective tissue a reliable indicator of tumor invasion in fine-needle aspiration of the breast? Maygarden SJ, Brock MS, Novotny DB. Diagn Cytopathol; 1997 Feb; 16(2):137-42. PubMed ID: 9067105 [Abstract] [Full Text] [Related]
15. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF. Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737 [Abstract] [Full Text] [Related]
16. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions? Masood S, Loya A, Khalbuss W. Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640 [Abstract] [Full Text] [Related]
19. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Nielsen BS, Rank F, López JM, Balbin M, Vizoso F, Lund LR, Danø K, López-Otín C. Cancer Res; 2001 Oct 01; 61(19):7091-100. PubMed ID: 11585740 [Abstract] [Full Text] [Related]